SA
ACHC icon

Shilanski & Associates’s Acadia Healthcare ACHC Stock Holding History

Shilanski & Associates’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,635
Closed -$1.19M – 124
2021
Q4 		$1.19M Sell
19,635
-220
-1% -$13.1K 0.51% 56
2021
Q3 		$1.27M Buy
19,855
+1,101
+6% +$69.5K 0.59% 52
2021
Q2 		$1.18M Buy
+18,754
New +$1.18M 0.56% 54

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Shilanski & Associates's ACHC Position: Q1 2022 in Review

Shilanski & Associates sold out of Acadia Healthcare (ACHC) in Q1 2022, closing a stake of 19,635 shares — an estimated $1.19M sold.

Shilanski & Associates first reported a position in ACHC in Q2 2021 and held it in 3 quarters. The position peaked at $1.27M in Q3 2021. 286 funds tracked by Wall St. Rank hold ACHC as of Q1 2022.

  • Shilanski & Associates reported no remaining Acadia Healthcare position as of Q1 2022 after selling out during the quarter.
  • Shilanski & Associates sold 19,635 Acadia Healthcare shares in Q1 2022, an estimated $1.19M.
  • Shilanski & Associates first reported a position in Acadia Healthcare in Q2 2021 and held it in 3 quarters.
  • Shilanski & Associates's Acadia Healthcare position peaked at $1.27M in Q3 2021.
  • 286 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2022.

Based on Shilanski & Associates's 13F filing for Q1 2022, filed 20 Apr 2022.